SC
CRL icon

Schubert & Co’s Charles River Laboratories CRL Stock Holding History

Schubert & Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$1.41K – 380
2023
Q1 		$1.41K Sell
7
-4
-36% -$907 ﹤0.01% 1051
2022
Q4 		$2.4K Buy
11
+8
+267% +$1.75K ﹤0.01% 778
2022
Q3 		$1K Sell
3
-4
-57% -$864 ﹤0.01% 1055
2022
Q2 		$1K Buy
7
+2
+40% +$489 ﹤0.01% 1045
2022
Q1 		$1K Sell
5
-4
-44% -$1.23K ﹤0.01% 633
2021
Q4 		$3K Buy
+9
New +$3.5K ﹤0.01% 212

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Schubert & Co's CRL Position: Q2 2023 in Review

Schubert & Co sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 7 shares — an estimated $1.41K sold.

Schubert & Co first reported a position in CRL in Q4 2021 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Schubert & Co reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 7 Charles River Laboratories shares in Q2 2023, an estimated $1.41K.
  • Schubert & Co first reported a position in Charles River Laboratories in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Charles River Laboratories position peaked at $3K in Q4 2021.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.